Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Natera, Inc. v. NeoGenomics Laboratories, Inc., No. 24-1324 (Fed. Cir. July 12, 2024)

Affirmed
Injunction Infringement
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 24-1324
Also Docketed
No. 24-1409 (consolidated; same document)
Decided
July 12, 2024
Judge
Moore, C.J.
Document
Precedential Opinion
Length
22 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

NeoGenomics Laboratories, Inc. (NeoGenomics) ap- peals the United States District Court for the Middle Dis- trict of North Carolina’s grant of a preliminary injunction barring NeoGenomics from making, using, selling, adver- tising, or distributing the RaDaR assay. We affirm. B ACKGROUND Natera, Inc. (Natera) and NeoGenomics are research - focused healthcare companies operating in the oncology testing industry. Both companies manufacture products used for early detection of cancer relapse.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error